Drug Trial Radar · NCT06227585
Feasibility and Efficacy Study for Bevonescein-Assisted Nerve Visualization in Head & Neck Surgery
Last checked: Nov 19, 2026Latest source record: Oct 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
155
Actual
Start
Nov 29, 2023
Primary completion
Oct 24, 2025
Study completion Jan 5, 2026
Sponsor
- Lead sponsor
- Alume Biosciences, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 29, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Part 1 Phase 2 feasibility study to characterize the feasibility of using the REVEAL 475 system by obtaining surgeon perspective on illumination and ease of use. A Part 2 Phase 3 safety and efficacy study to evaluate conspicuity of the identified nerve due to bevonescein through the use of the Visualization Scoring System (VSS).
Conditions
- Head and Neck Surgery
Interventions
REVEAL 475 SystemDevice
The REVEAL 475 system will be evaluated for its ability to visualize nerve-fluorescence following bevonescein administration.
BevonesceinDrug
All patients will receive a single dose of bevonescein 500 mg via IV infusion 1-5 hours before surgery.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part 1 Phase 2 Surgeon perspective on REVEAL 475 system blue light illuminationTime frame: Immediately after surgery
- Part 1 Phase 2 Surgeon perspective on REVEAL 475 system ease of useTime frame: Immediately after surgery
- Part 2 Phase 3 To demonstrate the efficacy of bevonescein to improve the Nerve ConspicuityTime frame: During Surgery
- Part 2 Phase 3 To demonstrate the efficacy of bevonescein to improve the Length Measurement of nerves that can be visualizedTime frame: During Surgery
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Alume Biosciences
La Jolla, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.